Sequenom, Inc. (Nasdaq: SQNM) today announced the formation of a new clinical advisory board focusing on retinal diseases and conditions. The initial three distinguished thought-leaders will provide guidance to Sequenom and Sequenom Center for Molecula…
AMD Update 13: Retinal Procedures on the Rise
A new study, just published in the October issue of Archives of Ophthalmology and reported by Ophthalmology Web, MedPage Today, and Medscape Medical News, shows that among those in the Medicare population (age 65 plus), treatments for retinal con…
No Significant Differences Found After LASEK, PRK
There was no significant difference between LASEK and PRK in odds ratio, weighted mean difference and standardized mean difference, according to a systematic review and meta-analysis study. However, LASEK-treated eyes had less corneal haze at 1 month a…
VisionCare’s Implantable Telescope For Macular Degeneration Featured In Presentations At Upcoming American Academy Of Ophthalmology Meeting
VisionCare Ophthalmic Technologies, Inc., a developer of advanced visual prosthetic devices, today announced upcoming scientific presentations on the company’s Implantable Miniature Telescope (by Dr. Isaac Lipshitz) which was recently approved by the F…
VisionCare’s Implantable Telescope For Macular Degeneration Featured In Presentations At Upcoming American Academy Of Ophthalmology Meeting
VisionCare Ophthalmic Technologies, Inc., a developer of advanced visual prosthetic devices, today announced upcoming scientific presentations on the company’s Implantable Miniature Telescope (by Dr. Isaac Lipshitz) which was recently approved by the F…
No Significant Differences Found After LASEK, PRK
There was no significant difference between LASEK and PRK in odds ratio, weighted mean difference and standardized mean difference, according to a systematic review and meta-analysis study. However, LASEK-treated eyes had less corneal haze at 1 month a…